Food and Drug Administration reviews model for predicting drug related liver injury
1. The Food and Drug Administration is reviewing an artificial intelligence based tool that could help predict drug induced liver ...
Tag: drug development
![2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/Untitled-design-350x250.png)
2MM: AI Roundup: Food and Drug Administration reviews liver injury prediction tool, Joint Commission launches healthcare artificial intelligence certification, governance playbooks aim to standardize adoption, and pediatric hospitals bring generative tools to the frontline
Food and Drug Administration reviews artificial intelligence tool for liver injury prediction The Food and Drug Administration (FDA) is reviewing ...
Why Pfizer Is Looking East for Its Next Generation of Cancer Drugs
1. Pfizer has committed $650 million upfront in a collaboration with Innovent Biologics that could ultimately reach $10.5 billion in ...
Food and Drug Administration to Fully Integrate Generative Artificial Intelligence by June
Key points:1. The Food and Drug Administration is preparing to launch an agency wide generative artificial intelligence system by the ...
2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [May 23rd, 2025]
Food and Drug Administration to Fully Integrate Generative Artificial Intelligence by JuneThe Food and Drug Administration is diving headfirst into ...
Evorpacept as single-agent or combination pembrolizumab or trastuzumab shows promise in the treatment of advanced solid tumours
1. This is the first human clinical trial of evorpacept, a CD47 inhibitor, and the results suggest an acceptable safety ...
